KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Chemed (CHE) Shares Repurchased (2016 - 2026)

Chemed filings provide 18 years of Shares Repurchased readings, the most recent being $190.0 million for Q1 2026.

  • For the quarter ending Q1 2026, Shares Repurchased rose 472.03% year-over-year to $190.0 million, compared with a TTM value of $588.3 million through Mar 2026, up 65.19%, and an annual FY2025 reading of $431.5 million, up 19.4% over the prior year.
  • Shares Repurchased hit $190.0 million in Q1 2026 for Chemed, up from $174.6 million in the prior quarter.
  • The five-year high for Shares Repurchased was $209.3 million in Q4 2024, with the low at $13.0 million in Q4 2022.
  • Median Shares Repurchased over the past 5 years was $42.9 million (2025), compared with a mean of $76.8 million.
  • The sharpest move saw Shares Repurchased plummeted 94.72% in 2022, then soared 472.03% in 2026.
  • Year by year, Shares Repurchased stood at $13.0 million in 2022, then soared by 207.71% to $39.9 million in 2023, then soared by 424.29% to $209.3 million in 2024, then decreased by 16.62% to $174.6 million in 2025, then grew by 8.87% to $190.0 million in 2026.
  • According to Business Quant data, Shares Repurchased over the past three periods came in at $190.0 million, $174.6 million, and $180.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.